Figures
. Binding pockets in APPTM calculated by AlphaSpace. AlphaSpace was used to calculate the potential binding pockets in APPTM based on our previously reported NMR structure (PDB: 2LZ3). We found two major binding pockets at the top and bottom of the APPTM helical dimer. Next, AutoDock Vina was employed for virtual screenings of the SPECS commercial database (www.specs.net). The top-scoring compounds were selected to for evaluation by NMR. was measured to be 78.9 µM when HEK 293 cells transduced with APP695 were treated with C1 for 24 h. Cytotoxicity of C1 was tested at the concentrations of 10, 25, 50, 100 and 1000 µM. The mean of three measurements was used to draw % of toxicity graph.
Materials and Methods

Protein expression and purification.
The overexpression and purification of APPTM were described previously by our group 4 and others 5, 6 . Using the pETM41 vector, the MBP-APPTM-His 6 fusion protein was successfully overexpressed in E. coli BL21 DE3 Condon Plus RIPL cells. The fusion protein was used as the substrate in gel-based cleavage assay by PSH MAMRE50. The fusion protein was cleaved by thrombin to generate isotopically labeled APPTM for NMR studies. APPTM was reconstituted into micelles to yield high quality 2D 1 H-15 N TROSY spectra. Lysine mutants of APPTM were overexpressed and purified using the same protocol with modified plasmids created by site directed mutagenesis. The presenilin homolog (PSH) MAMRE50 was overexpressed and purified using the protocol by J.W. Cooley et al. 7 .
Solution NMR
Following purification, APPTM was buffer exchanged into NMR buffer (25 mM sodium phosphate, pH=7.2) where the final dodecyl phosphocholine (DPC) (Anatrace, Maumee, OH) concentration was adjusted to 4%. Well-resolved 1 H-15 N TROSY spectra were recorded in 10% D 2 O on an 800 MHz Bruker Advance II spectrometer equipped with cryogenic probes. The assignment of the 1 H-15 N TROSY spectrum of APPTM was previously accomplished and deposited in BMRB (Entry 18649) 8 .
Compound C1 was added to 15 N-labeled APPTM sample at a ratio of 1:5. 1 H-15 N TROSY spectra were collected for APPTM before and after adding C1 at 323K. The spectra were analyzed using Sparky (T.D. Goddard AND D.G. Kneller, SPARKY 3, University of California, San Francisco, CA) and Microsoft Excel. The intensity changes of each resonance peak caused by C1 were calculated by I/I 0 , where I and I 0 represent the peak intensity after and before C1 addition, respectively. The calculated I/I 0 was plotted against amino acid residues from the N-to C-terminus of APPTM to map the binding site. 1D 1 H spectrum of 2-naphtol was recorded in same NMR buffer and compared with the spectrum of APPTM-C1 mixture.
MALDI-TOF-MS and LC-ESI-FTMS
MALDI-TOF-MS and LC-ESI-FTMS were applied for the detection of C1 modification. All reactions were carried out using 15 
STD NMR
STD spectra were recorded at 313K on a Bruker 600 MHz NMR spectrometer. 1 mM C1 was mixed with 10 µM APPTM, dissolved in NMR buffer. 1D STD-NMR spectra were recorded with 1440 scans and selective saturation of protein resonances at 0 ppm using a series of Gaussian shaped pulses, for a total saturation time of 2.0 s. For certain experiments, a 30 ms spin lock was also employed to suppress peptide signals that overlap C1 resonances. Saturation transfer reference (STR) spectrum was recorded by off-resonance frequency set to -10.0 ppm. STD spectrum of 1mM C1 in the absence of APPTM was conducted under the same parameters as a negative control.
Gel-based cleavage assay by PSH MAMRE50
A gel-based assay was established to test the cleavage of APPTM and C1-modified APPTM by PSH MAMRE50. The fusion protein MBP-APPTM (1 µM) was used as the substrate and modified by different ratio of C1 (1:2, 1:10, and 1:20) before cleaved by PSH. Residual C1 and reaction product 2-naphthol were removed by a desalting column. The native and C1-modified substrate were incubated with 5 µM of PSH at 37° for 24 h before running on a 12% SDS-PAGE gel. III-31-C, a known -secretase inhibitor, was pre-incubated with PSH for 1h before adding the substrate.
For the substrate competition assay, different amounts (0.5, 1, 2, 5 or 10 µM) of C1 modified MBP-APPTM were added to 1 µM native substrate and 5 µM PSH mixture, and incubated at 37 °C for 24 h before running on a 12% SDS-PAGE gel. Same protocol was used for the gel-based cleavage assay of lysine mutants.
-secretase cleavage by AlphaLISA assay
A well-established AlphaLISA assay [9] [10] [11] was employed to test if C1-modified substrate can inhibit the -secretase cleavage in vitro. HeLa-S3 cell was purchased from National Cell Culture Center and solubilized membrane was prepared as previously described 10, 12 . The Sb4 substrate based on the sequence of APP (1 µM) was incubated with 1:0.001, 1:0.01, 1:0.1, 1:0.5, 1:1, 1:5, 1:10 and 1:50 ratio of C1 at 37 °C for 4 h. After shaking with solubilized -secretase (40 µg/mL) at 110 rpm for 3 h at 37 °C, the AlphaLISA detection mixture that includes A40 and A42 antibody (G2-10 and 10G3, respectively), protein A-conjugated acceptor beads, streptavidin-conjugated donor beads were added and incubated overnight. The AlphaLISA signal was detected using Envision plate reader (Perkin Elmer, Waltham, MA). Data were processed using GraphPad Prism (version 8.1.0). IC 50 value was fitted by a non-linear regression equation:
where Y m and Y 0 represent the highest and lowest A level, respectively, and X is C1 concentration.
Cell culture methods
HEK293 cells were stably transfected with human APP695 in pMX-IRES-GFP vector purchased from GenScript, Piscataway, NJ as described previously 13 . HEK293 expressing APP695 were grown in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum, penicillin and streptomycin. For both toxicity assay and soluble Aβ level detection, the medium was collected after APP695-HEK293 cells were treated with C1 for 24 h Cell viability was evaluated by the 3-[4,5-dimethy-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction method using cell proliferation kit (Sigma-Aldrich, St. Louis, MO). The absorbance at 570 nm (formazan product) minus the absorbance at 630 nm (background) was recorded according to manufacturer's instruction. The corrected absorbance was used to calculate the percent cell viability by using the following formula for each sample: (corrected Absorbance of experiment-corrected Absorbance of blank)/(corrected Absorbance of DMSO control-corrected Absorbance of blank)*100. The concentration of Aβ in conditioned medium was measured by A40 and A42 specific ELISAs (Life Technologies, Carlsbad, CA), respectively, as described previously 14 . The absorbance was determined for each well at 450 nm using a microplate reader (Bio-Rad, Hercules, CA).
